intra-individual platelet activation, as meased by PFA-200, at different time lapses after aspirin intake

intra-individual platelet activation, as meased by PFA-200, at different time lapses after aspirin intake - Platelet activation in aspirin users, as measured by PFA-200

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39536

Enrollment

Registered

2013-02-08

Start date

2013-07-15

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute thrombo-embolische aandoeningen (cq. myocardinfarct, herseninfarct) Acute thromboembolic events

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Outpatients from the cardiology and vascular surgery departments. Intake of respectively 100 mg or 80 mg of carbasalate calcium or acetylsalicylic acid once a day.

Exclusion criteria

Exclusion criteria: * active bleeding * thrombocytopenia * thrombocytosis * recent use of antiplatet drugs, anticoagulants or drugs that are known to alter platelelet function, other than aspirin (e.g. NSAID*s, tirofiban, eptifibatide, abciximab, beta-lactam antibiotics, dextran, SSRI*s, clomipramine & amitriptyline, dipyridamole, verapamil, diltiazem , ginkgo biloba, ginseng, St John*s wort)

Design outcomes

Primary

Measure	Time frame
platelet activability as measured by PFA-200	—

Secondary

Measure	Time frame
platelet count platelet activability as measured by chronolog hemoglobone	—

Countries

Netherlands

Outcome results